41 related articles for article (PubMed ID: 1400430)
1. Absence of the proteoglycan decorin reduces glucose tolerance in overfed male mice.
Svärd J; Røst TH; Sommervoll CEN; Haugen C; Gudbrandsen OA; Mellgren AE; Rødahl E; Fernø J; Dankel SN; Sagen JV; Mellgren G
Sci Rep; 2019 Mar; 9(1):4614. PubMed ID: 30874564
[TBL] [Abstract][Full Text] [Related]
2. Reassessing target antigens for adoptive T-cell therapy.
Hinrichs CS; Restifo NP
Nat Biotechnol; 2013 Nov; 31(11):999-1008. PubMed ID: 24142051
[TBL] [Abstract][Full Text] [Related]
3. Antigens in chronic myeloid leukemia: implications for vaccine development.
Smahel M
Cancer Immunol Immunother; 2011 Dec; 60(12):1655-68. PubMed ID: 22033582
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of current cancer immunotherapy: hemato-oncology.
Hourigan CS; Levitsky HI
Cancer J; 2011; 17(5):309-24. PubMed ID: 21952281
[TBL] [Abstract][Full Text] [Related]
5. Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener’s granulomatosis.
Bruner BF; Vista ES; Wynn DM; Harley JB; James JA
Clin Exp Immunol; 2010 Nov; 162(2):262-70. PubMed ID: 21077276
[TBL] [Abstract][Full Text] [Related]
6. K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.
Smith BD; Kasamon YL; Kowalski J; Gocke C; Murphy K; Miller CB; Garrett-Mayer E; Tsai HL; Qin L; Chia C; Biedrzycki B; Harding TC; Tu GH; Jones R; Hege K; Levitsky HI
Clin Cancer Res; 2010 Jan; 16(1):338-47. PubMed ID: 20048335
[TBL] [Abstract][Full Text] [Related]
7. Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation.
Rezvani K; Barrett AJ
Best Pract Res Clin Haematol; 2008 Sep; 21(3):437-53. PubMed ID: 18790448
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for myeloid leukemias: current status and future directions.
el-Shami K; Smith BD
Leukemia; 2008 Sep; 22(9):1658-64. PubMed ID: 18563174
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-derived Oxidants and Proteinases as Immunomodulatory Mediators in Inflammation.
Witko-Sarsat V; Descamps-Latscha B
Mediators Inflamm; 1994; 3(4):257-73. PubMed ID: 18472951
[TBL] [Abstract][Full Text] [Related]
10. Housekeeping and tissue-specific genes in mouse tissues.
Kouadjo KE; Nishida Y; Cadrin-Girard JF; Yoshioka M; St-Amand J
BMC Genomics; 2007 May; 8():127. PubMed ID: 17519037
[TBL] [Abstract][Full Text] [Related]
11. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
van der Geld YM; Stegeman CA; Kallenberg CG
Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
[TBL] [Abstract][Full Text] [Related]
12. MCF-7 mammary tumour cells express the myeloid cell differentiation controlling factor, serine protease 3/myeloblastin.
Horman S; Fokan D; Galand P
Cell Prolif; 2000 Oct; 33(5):331-40. PubMed ID: 11063135
[TBL] [Abstract][Full Text] [Related]
13. Recombinant proteinase 3 (Wegener's antigen) expressed in Pichia pastoris is functionally active and is recognized by patient sera.
Harmsen MC; Heeringa P; van der Geld YM; Huitema MG; Klimp A; Tiran A; Kallenberg CG
Clin Exp Immunol; 1997 Nov; 110(2):257-64. PubMed ID: 9367410
[TBL] [Abstract][Full Text] [Related]
14. A myeloblastin/proteinase-3 cDNA clone identifies a BglII and a PvuII restriction fragment length polymorphism.
Schwaller J; Chen T; Fey MF; Tobler A
Hum Genet; 1993 Nov; 92(5):525. PubMed ID: 7902320
[TBL] [Abstract][Full Text] [Related]
15. Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen.
Sturrock AB; Franklin KF; Rao G; Marshall BC; Rebentisch MB; Lemons RS; Hoidal JR
J Biol Chem; 1992 Oct; 267(29):21193-9. PubMed ID: 1400430
[TBL] [Abstract][Full Text] [Related]
16. Localization of the gene encoding proteinase-3 (the Wegener's granulomatosis autoantigen) to human chromosome band 19p13.3.
Sturrock AB; Espinosa R; Hoidal JR; Le Beau MM
Cytogenet Cell Genet; 1993; 64(1):33-4. PubMed ID: 8508676
[TBL] [Abstract][Full Text] [Related]
17. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties.
Rao NV; Wehner NG; Marshall BC; Gray WR; Gray BH; Hoidal JR
J Biol Chem; 1991 May; 266(15):9540-8. PubMed ID: 2033050
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis.
Brockmann H; Schwarting A; Kriegsmann J; Petrow P; Gaumann A; Müller KM; Galle PR; Mayet W
Arthritis Res; 2002; 4(3):220-5. PubMed ID: 12010574
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
